ImmunityBio
IBRX
IBRX
126 hedge funds and large institutions have $311M invested in ImmunityBio in 2021 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 51 increasing their positions, 26 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
20% less capital invested
Capital invested by funds: $390M → $311M (-$78.7M)
61% less call options, than puts
Call options by funds: $5.03M | Put options by funds: $13M
Holders
126
Holding in Top 10
1
Calls
$5.03M
Puts
$13M
Top Buyers
| 1 | +$14.3M | |
| 2 | +$10.9M | |
| 3 | +$5.57M | |
| 4 |
D.E. Shaw & Co
New York
|
+$2.86M |
| 5 |
BlackRock
New York
|
+$2.71M |
Top Sellers
| 1 | -$3.57M | |
| 2 | -$3.03M | |
| 3 | -$1.27M | |
| 4 |
EGM
Engineers Gate Manager
New York
|
-$1.25M |
| 5 |
Two Sigma Investments
New York
|
-$1.22M |